Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pediatrix Medical Group, Inc.MD · Entity 4451 | EVP, CFO and Treasurer | June 01, 2026 | June 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pediatrix Medical Group, Inc.
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 101,399 |
Ending reported balance
After 2026-06-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-01 · Grant · Acquired 31,800 · Balance 105,100 F1: Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan. Row 2 · 2026-06-01 · Tax withholding · Disposed 3,701 · Balance 101,399 F2: Represents 3,701 restricted shares withheld for payment of taxes upon vesting of shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan.
F2: Represents 3,701 restricted shares withheld for payment of taxes upon vesting of shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 3,701 | $21.54 | $79,719.54 |
DisclosureSEC source: 0001193125-26-255710 · ownership.xml · nonDerivative · entry 2 Rossi Kasandra H · CIK 0002037773 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,399 F2 · kind: Represents 3,701 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 31,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-255710 · ownership.xml · nonDerivative · entry 1 Rossi Kasandra H · CIK 0002037773 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,100 F1 · kind: Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 3,676 | $19.85 | $72,968.60 |
DisclosureSEC source: 0001193125-26-088620 · ownership.xml · nonDerivative · entry 1 Rossi Kasandra H · CIK 0002037773 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,300 F1 · kind: Represents 3,676 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 677 | $14.15 | $9,579.55 |
DisclosureSEC source: 0000950170-25-081079 · ownership.xml · nonDerivative · entry 2 Rossi Kasandra H · CIK 0002037773 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,976 F2 · kind: Represents 677 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 26,502 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-081079 · ownership.xml · nonDerivative · entry 1 Rossi Kasandra H · CIK 0002037773 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,653 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2026, twenty-five percent (25%) of the restricted shares will vest on June 1, 2027 and fifty percent (50%) of the restricted shares will vest on June 1, 2028, subject to the terms of the Plan. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 3,718 | $14.77 | $54,914.86 |
DisclosureSEC source: 0000950170-25-032354 · ownership.xml · nonDerivative · entry 1 Rossi Kasandra H · CIK 0002037773 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,151 F1 · kind: Represents 3,718 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 11,112 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-132838 · ownership.xml · nonDerivative · entry 1 Rossi Kasandra H · CIK 0002037773 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,869 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2025, twenty-five percent (25%) of the restricted shares will vest on June 1, 2026 and fifty percent (50%) of the restricted shares will vest on June 1, 2027, subject to the terms of the Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.